ABT vs EW
Abbott Laboratories (ABT) and Edwards Lifesciences (EW) compared side by side. Abbott Laboratories (ABT) is larger, with a market cap of $179.4B versus $51.3B for Edwards Lifesciences, about 3.5 times the size. On trailing earnings, ABT is cheaper at 38.6x versus 53.0x for EW.
Head to head
| Metric | ABT | EW |
|---|---|---|
| Market cap | $179.4B | $51.3B |
| P/E (TTM) | 38.6x | 53.0x |
| Forward P/E | 17.4x | 26.3x |
| Revenue (TTM) | $48.2B | $6.5B |
| Revenue growth | 14.5% | 13.6% |
| Gross margin | 57.1% | 77.8% |
| Operating margin | 11.3% | 29.8% |
| Free cash flow | $7.4B | $1.4B |
| Dividend yield | 2.43% | None |
| 1-year return | -15.9% | +16.4% |
| 5-year return (annual) | -2.0% | -5.2% |
| Max drawdown | -46% | -54% |
| FI Handbook grade | C+ | B- |
Highlighted: the stronger figure on metrics where higher or lower is clearly better.
Growth of $10,000 (5 years, price only)
ABT vs EW FAQ
Which is bigger, ABT or EW?
Abbott Laboratories (ABT) is larger, with a market cap of $179.4B versus $51.3B for Edwards Lifesciences, about 3.5 times the size.
Is ABT or EW cheaper?
On trailing earnings, ABT is cheaper at 38.6x versus 53.0x for EW. A lower P/E can reflect slower expected growth, so compare growth and margins too.
Which stock performed better over the past year, ABT or EW?
EW returned +16.4% over the past year including dividends, versus -15.9% for ABT, through October 23, 2026.
Which pays a higher dividend, ABT or EW?
ABT yields 2.43%; EW does not pay a dividend.
Full pages: Abbott Laboratories · Edwards Lifesciences